Lymphoma & Plasma Cell Disorders
News
Gel shows promise for treating early stage MF
LONDON—Results of a phase 2 trial suggest the topical histone deacetylase (HDAC) inhibitor remetinostat can elicit responses in patients with...
News
Cryotherapy can reduce signs of CIPN
A new study suggests cryotherapy can reduce symptoms of chemotherapy-induced peripheral neuropathy (CIPN). Researchers found that having...
News
Natural selection opportunities tied to cancer rates
Countries with the lowest opportunities for natural selection have higher cancer rates than countries with the highest opportunities for natural...
News
NCCN completes resource on radiation therapy
The National Comprehensive Cancer Network® (NCCN) has announced the release of the newly completed NCCN Radiation Therapy Compendium™. This...
News
Predicting neurotoxicity after CAR T-cell therapy
Researchers say they have identified potential biomarkers that may be used to help identify patients at an increased risk of neurotoxicity after...
News
Immunotherapy demonstrates potential for T-cell lymphoma
Researchers have reported successful inhibition of the phosphatase SHIP1, which may be an effective approach for treating T-cell lymphoma. The...
News
FDA rejects pegfilgrastim biosimilar
The US Food and Drug Administration (FDA) has issued a complete response letter saying the agency cannot approve MYL-1401H, a proposed biosimilar...
News
Team identifies genetic drivers of DLBCL
Research published in Cell has revealed 150 genetic drivers of diffuse large B-cell lymphoma (DLBCL). Among these drivers are 27 genes newly...
News
Primary care may be inadequate for cancer survivors
Primary care may not meet the healthcare needs of cancer survivors in the US, according to research published in JAMA Internal Medicine....
From the Journals
Obinutuzumab edges out rituximab for PFS in follicular lymphoma
Three-year progression-free survival was 80% with obinutuzumab, vs. 73.3% with rituximab.
From the Journals
Rare type of MCL mimics Castleman disease
Careful flow cytometric analysis is recommended when a histopathological diagnosis is made.